✦ LIBER ✦

Elevated plasma TGF-β1 levels correlate with decreased survival of metastatic breast cancer patients

✍ Scribed by Vesna Ivanović; Miroslav Demajo; Koviljka Krtolica; Milena Krajnović; Miroslav Konstantinović; Vladimir Baltić; Gordana Prtenjak; Bratislav Stojiljković; Milan Breberina; Zora Nes˘ković-Konstantinović; Dragica Nikolić-Vukosavljević; Bogomir Dimitrijević

Book ID: 116347176
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 98 KB
Volume: 371
Category: Article
ISSN: 0009-8981
DOI: 10.1016/j.cca.2006.02.027

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Elevated plasma levels of TGF-β1 in pati

Elevated plasma levels of TGF-β1 in patients with invasive prostate cancer

✍ Ivanovic, Vesna; Melman, Arnold; Davis-Joseph, Brian; Valcic, Mira; Geliebter, J 📂 Article 📅 1995 🏛 Nature Publishing Group 🌐 English ⚖ 478 KB

Elevated plasma levels of transforming g

Elevated plasma levels of transforming growth factor-β1 (TGF-β1) in patients with advanced breast cancer: association with disease progression

✍ Vesna Ivanović; Nataša Todorović-Raković; Miroslav Demajo; Zora Nešković-Konstan 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 166 KB

Elevated plasma tissue inhibitor of meta

Elevated plasma tissue inhibitor of metalloproteinase-1 level predicts decreased response and survival in metastatic breast cancer

✍ Allan Lipton; Suhail M. Ali; Kim Leitzel; Laurence Demers; Dean B. Evans; Peter 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 151 KB

## Abstract ## BACKGROUND. Tissue inhibitors of metalloproteinase (TIMPs) have at least 2 different functions. They inhibit the catalytic activity of matrix metalloproteinases, and they act as growth factors. ## METHODS. Pretreatment ethylenediamine tetracetic acid plasma TIMP‐1 was assayed from

Elevated plasma levels of transforming g

Elevated plasma levels of transforming growth factor (TGF)-β1 and TGF-β2 in patients with disseminated malignant melanoma

✍ Krasagakis, K; Thölke, D; Farthmann, B; Eberle, J; Mansmann, U; Orfanos, CE 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 474 KB

Elevated plasma tissue inhibitor of meta

Elevated plasma tissue inhibitor of metalloproteinase-1 levels predict decreased survival in castration-resistant prostate cancer patients

✍ William K. Oh; Roberto Vargas; Susanna Jacobus; Kim Leitzel; Meredith M. Regan; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 220 KB

## Abstract ## BACKGROUND. Tissue inhibitor of metalloproteinase‐1 (TIMP‐1) has paradoxical multifunctional roles in tumorigenesis: inhibition of the catalytic activity of matrix metalloproteinases and apoptosis as well as promotion of angiogenesis and tumor growth. Elevated TIMP‐1 levels have bee

Plasma levels of soluble CD105 correlate

Plasma levels of soluble CD105 correlate with metastasis in patients with breast cancer

✍ Chenggang Li; Baoqiang Guo; Phillip B. Wilson; Alan Stewart; Ged Byrne; Nigel Bu 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 72 KB 👁 2 views

CD105 (endoglin), a receptor for transforming growth factor (TGF) ␤1 and ␤3 in vascular endothelial cells, is highly up-regulated in blood vessels of tissues where neovascularisation occurs. It modulates endothelial-mesenchymal signalling and is essential for angiogenesis. Indeed, CD105 knockout mic